ONE YEAR FOLLOW UP IN THREE PHASE IB/IIA CLINCIAL TRIALS OF EX VIVO EXPANDED ALLOGENEIC BONE MARROW DERIVED MESENCHYMAL STEM CELLS FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE

被引：0
|
作者：
Lightner, Amy L.
Pineiro, Ana Otero
Reese, Jane
Ream, Justin
Nachand, Douglas
Adams, Ashley
VanDenBossche, Alexandra
Dadgar, Neda
Hull, Tracy L.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
325
引用
收藏
页码：S1470 / S1471
页数：2
相关论文
共 49 条
  • [1] One Year Follow up of Three Phase IB/IIA Clinical Trials of Ex Vivo Expanded Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulizing Crohn's Disease
    Lightner, A.
    Pineiro, A. Otero
    Reese, J.
    Ream, J.
    Nachand, D.
    Obi, M.
    Adams, A.
    VanDenBossche, A.
    Dadgar, N.
    Hull, T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 555 - 555
  • [2] A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease
    Lightner, Amy L.
    Reese, Jane
    Ream, Justin
    Nachand, Douglas
    Jia, Xue
    Dadgar, Neda
    Steele, Scott R.
    Hull, Tracy
    DISEASES OF THE COLON & RECTUM, 2023, 66 (10) : 1359 - 1372
  • [3] Comments on: "A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone-Marrow Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease"
    Cheng, Fang
    DISEASES OF THE COLON & RECTUM, 2024, 67 (03) : E202 - E202
  • [4] A phase IB/IIA study of ex vivo expanded allogeneic bone marrowederived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn's disease
    Lightner, Amy L.
    Reese, Jane S.
    Ream, Justin
    Nachand, Douglas
    Dadgar, Neda
    Adams, Ashley
    Vandenbossche, Alexandra
    Pineiro, Ana Otero
    Hull, Tracy
    SURGERY, 2024, 175 (02) : 242 - 249
  • [5] Comment on "A phase IB/IIA study of ex vivo expanded allogeneic bone-marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn disease. "
    Cheng, Fang
    SURGERY, 2024, 175 (05) : 1463 - 1464
  • [6] A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease
    Pineiro, A. Otero
    Lightner, A. L.
    Reese, J.
    Ream, J.
    Nachand, D.
    Adams, A.
    VanDenBossche, A.
    Kurowski, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 848 - 848
  • [7] A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease
    Lightner, Amy L.
    Otero-Pineiro, Ana
    Reese, Jane
    Ream, Justin
    Nachand, Douglas
    Adams, Ashley C.
    VanDenBossche, Alexandra
    Kurowski, Jacob A.
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (12) : 1912 - 1919
  • [8] Direct Injection of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Crohn's Perianal Fistulizing Disease
    Lightner, Amy L.
    Kurowski, Jacob
    Otero-Pinerio, Ana M.
    DISEASES OF THE COLON & RECTUM, 2024, 67 (02) : E115 - E116
  • [9] Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months
    Lightner, Amy L.
    Pineiro, Ana Otero
    Reese, Jane
    Ream, Justin
    Nachand, Douglas
    Adams, Ashley C.
    Dadgar, Neda
    Hull, Tracy
    SURGERY, 2024, 175 (04) : 984 - 990
  • [10] A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease
    Swaroop, Shekhar
    Vuyyuru, Sudheer Kumar
    Kante, Bhaskar
    Kumar, Peeyush
    Mundhra, Sandeep Kumar
    Arora, Umang
    Goyal, Ankur
    Kandasamy, Devasenathipathy
    Sharma, Raju
    Kabilan, Kavirajan
    Kedia, Saurabh
    Dash, Nihar Ranjan
    Ahuja, Vineet
    STEM CELL RESEARCH & THERAPY, 2024, 15 (01)
12345